FDA Inspection 612640 — Jilin Shulan Synthetic Pharmaceutical Co. Ltd.
The FDA completed an inspection of Jilin Shulan Synthetic Pharmaceutical Co. Ltd. on August 28, 2009 in Jilin. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 28, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jilin (China)